The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18 F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer

Prostate-specific membrane antigen (PSMA; also termed glutamate carboxypeptidase II (GCP II)) is abundantly expressed in prostate cancer. It has been shown recently that PSMA is expressed in neovasculature of differentiated thyroid cancer. In this study, we show that F-DCFPyl might detect neovascula...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical oncology (Northwood, London, England) London, England), 2020-10, Vol.37 (11), p.98
Hauptverfasser: Santhanam, Prasanna, Russell, Jonathon, Rooper, Lisa M, Ladenson, Paul W, Pomper, Martin G, Rowe, Steven P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!